Tides CDMO Services

Our platform integrates 4 R&D powerhouses: peptides, oligonucleotides and drug delivery materials, to offer end-to-end CMC solutions. From pre-clinical to commercial triumphs, we empower global clients with unparalleled expertise. With a team of over 150 scientists, we won a robust track record of over 100 satisfied customers and 30+ projects spanning IND to NDA stages, Porton Pharma stands as a beacon of innovation. Driving advancements in linear and cyclic peptide synthesis (<50 aa), along with sophisticated modifications , We also excel in oligonucleotide realms, including ASO, siRNA, and sgRNA, tailored to meet diverse therapeutic demands. Porton Pharma's service spectrum is vast, covering preclinical sample prep, process scaling (non-GMP & GMP), formulation, and analytical method development. We streamline IND/NDA submissions, making regulatory pathways smoother. We're not a service provider; we're your partner in accelerating drug development.